Efficacy of tenofovir as intensification of zidovudine/lamivudine/abacavir fixed-dose combination in the treatment of HIV-positive patients

被引:8
|
作者
Khanlou, H [1 ]
Guyer, B
Farthing, C
机构
[1] AIDS Healthcare Fdn, Los Angeles, CA USA
[2] Gilead Sci Inc, Foster City, CA 94404 USA
关键词
D O I
10.1097/01.qai.0000159322.21133.74
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:627 / 628
页数:2
相关论文
共 50 条
  • [1] Fixed-dose combination of abacavir, lamivudine and zidovudine for HIV therapy
    Milinkovic, Ana
    Mallolas, Jop
    [J]. FUTURE VIROLOGY, 2007, 2 (01) : 23 - 30
  • [2] Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV
    Chad J. Achenbach
    Kimberly K. Scarsi
    Robert L. Murphy
    [J]. Advances in Therapy, 2010, 27 : 1 - 16
  • [3] Abacavir/Lamivudine Fixed-Dose Combination Antiretroviral Therapy for the Treatment of HIV
    Achenbach, Chad J.
    Scarsi, Kimberly K.
    Murphy, Robert L.
    [J]. ADVANCES IN THERAPY, 2010, 27 (01) : 1 - 16
  • [4] Erratum to: Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV
    Chad J. Achenbach
    Kimberly K. Scarsi
    Robert L. Murphy
    [J]. Advances in Therapy, 2010, 27 : 127 - 127
  • [5] Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection
    Keiser, Philip
    Nassar, Naiel
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (04) : 477 - 483
  • [6] Abacavir/lamivudine fixed-dose combination tablet for the treatment of HIV-1 infection
    Taylor, Clare L.
    Wilkins, Edmund G. L.
    [J]. FUTURE VIROLOGY, 2007, 2 (01) : 11 - 21
  • [7] Early versus Delayed Fixed Dose Combination Abacavir/Lamivudine/Zidovudine in Patients with HIV and Tuberculosis in Tanzania
    Shao, Humphrey J.
    Crump, John A.
    Ramadhani, Habib O.
    Uiso, Leonard O.
    Ole-Nguyaine, Sendui
    Moon, Andrew M.
    Kiwera, Rehema A.
    Woods, Christopher W.
    Shao, John F.
    Bartlett, John A.
    Thielman, Nathan M.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (12) : 1277 - 1285
  • [8] Zidovudine/Lamivudine vs. Abacavir/Lamivudine vs. Tenofovir/Emtricitabine in fixed-dose combinations as initial treatment for HIV patients: a systematic review and network meta-analysis
    Alzate Angel, Juan Carlos
    Duque Molina, Marcela Maria
    Garcia Garcia, Hector Ivan
    [J]. COLOMBIA MEDICA, 2017, 48 (02): : 70 - 81
  • [9] Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV
    Sturmer, Martin
    Staszewski, Schlomo
    Doerr, Hans Wilhelm
    [J]. ANTIVIRAL THERAPY, 2007, 12 (05) : 695 - 703
  • [10] Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
    Bouazza, Naim
    Cressey, Tim R.
    Foissac, Frantz
    Bienczak, Andrzej
    Denti, Paolo
    McIlleron, Helen
    Burger, David
    Penazzato, Martina
    Lallemant, Marc
    Capparelli, Edmund V.
    Treluyer, Jean-Marc
    Urien, Saik
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (02) : 490 - 495